ASSEMBLY BIOSCIENCES, INC. ASMB

About ASSEMBLY BIOSCIENCES, INC. (ASMB): stock profile, AI score and financials

ASSEMBLY BIOSCIENCES, INC. (ASMB) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ASMB at 42.1/100 on a composite quality score built from its SEC filings, placing it at rank #2,025 of 2,925 stocks — the bottom half of the AI-ranked universe. ASMB scores in the top quartile across revenue growth (96.0), institutional flow (83.3). Areas of concern include earnings quality (1.0) and free cash flow (6.9), which score below median versus the broader universe. Shareholder dilution risk is elevated at 20.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), ASSEMBLY BIOSCIENCES, INC. reports quarterly revenue of $13.4M, net income of $-3.9M, an operating margin of -47.4%. ASMB trades on the Nasdaq exchange and files with the SEC under CIK 1426800. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ASMB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ASSEMBLY BIOSCIENCES, INC. directly from SEC EDGAR.

SEC EDGAR: CIK 1426800 →